The scandal and its repercussions will be felt deep into Big Pharma’s operations in emerging markets, causing a fundamental shift in product marketing approaches involving physicians.
A judge has finalized a $190 million settlement between Johns Hopkins Hospital and more than 8,...
A Baltimore judge was set to hear objections Friday to a preliminary $190 million dollar...
A Detroit-area cancer doctor accused of putting people through unnecessary treatments and then billing insurers for millions of dollars pleaded guilty to fraud Tuesday, admitting that he knew his patients often didn't need chemotherapy.
Some of the nation's largest cities are ratcheting up their criticism of prescription painkillers, blaming the industry for a wave of addiction and overdoses that have ravaged their communities and busted local budgets.
New York's attorney general filed a federal lawsuit Monday seeking to stop a manufacturer from discontinuing its drug widely used to treat Alzheimer's patients, arguing the company is illegally driving patients to its newer patented drug to avoid losses from cheaper generic alternatives coming out next year.
The Food and Drug Administration is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use skin shocks as aversive conditioning for aggressive patients.
The powerful chemical industry is putting its lobbying muscle behind legislation that would establish standards for chemicals used in products from household goods to cellphones and plastic water bottles — but also make it tougher for states to enact their own regulations.
The Department of Justice filed a court motion against the German conglomerate over its advertisements for Phillips' Colon Health, which claims to prevent diarrhea, constipation, gas and bloating. Federal officials say the company does not have reliable scientific evidence to support those claims.
A pharmacist who worked for a Massachusetts company blamed for a nationwide meningitis outbreak that killed 64 people pleaded not guilty to a mail fraud charge as his lawyer said he is concerned he could be made a scapegoat.
A multimillionaire mom killed her autistic 8-year-old son by forcing a toxic cocktail of painkillers and other drugs down his throat with a syringe in a luxury Manhattan hotel room, a prosecutor said as her murder trial opened Wednesday.
A new batch of lawsuits challenge the White House’s mandate that requires employers to provide contraception for employees.
An FBI official in Detroit confirmed that the bureau is looking at an Oregon research center, and investigators have raided facilities in Michigan and Arizona. Besides confirming the existence of an investigation, authorities have been tight-lipped about what they are examining and why.
A former portfolio manager convicted of helping his firm earn more than a quarter-billion dollars illegally through insider trading on a promising Alzheimer's drug trial was sentenced Monday to nine years in prison by a judge who said lengthy incarceration was earned with a staggering fraud that was the biggest of its kind.
The FTC says AbbVie and its partner and Besins Healthcare filed baseless patent infringement lawsuits against Teva Pharmaceutical Industries Ltd. and Perrigo Co. to delay the approval and sale of less-expensive generic versions of the drug.
Hyperion Therapeutics Terminates Diabetes Program - Discovers Serious Misconduct by Andromeda BiotechSeptember 8, 2014 8:35 am | News | Comments
Hyperion Therapeutics today announced it is terminating development of DiaPep277 for newly diagnosed Type 1 diabetes. The company has uncovered evidence that certain employees of Andromeda Biotech, which Hyperion acquired in June 2014, engaged in serious misconduct, including collusion with a third-party biostatistics firm.
Nuvo Research Inc. today announced that it has reached a full settlement with Mallinckrodt Inc. of Nuvo's claims and Mallinckrodt's counterclaim relating to Nuvo's license to Mallinckrodt of the right to market and sell Pennsaid and Pennsaid 2% in the United States.
Various unapproved and improperly labeled drug products that were marketed, sold and distributed via the Internet by Flawless Beauty LLC, of Asbury Park, New Jersey, have been seized by U.S. Marshals at the request of the U.S. Food and Drug Administration and the U.S. Attorney for the District of New Jersey.
Takeda Pharmaceutical has been ordered by a U.S. district court to pay $6 billion in punitive damages over a lawsuit filed by a man who claimed his bladder cancer was caused by Takeda's diabetes medicine Actos.
Teva Pharmaceutical announced that a positive judgment has been given by the UK High Court in support of Teva's case against AstraZeneca relating to the validity of EP 1,085,877 covering the SMART ( S ingle inhaler M aintenance A nd R eliever T herapy) indication for AstraZeneca's fixed dose formoterol/budesonide combination product, Symbicort®.
British, Hungarian and Austrian police were involved in the sweep that culminated Monday in eight arrests, including the suspected head of the scam in Vienna, police said.
Foreign companies in China feel increasingly targeted for unfair enforcement of anti-monopoly and other laws and might cut investment if conditions fail to improve, a U.S. business group said Tuesday.
DuPont will pay a fine of $1.275M to settle a federal complaint over eight chemical releases from a Kanawha County production facility, one of which killed a worker. The Department of Justice and U.S. Environmental Protection Agency said the settlement announced in a statement Wednesday resolves several alleged violations of federal law.
One of Japan’s leading research institutions, the prestigious Riken Institute, will scale down the center at the heart of a stem-cell research scandal earlier this year.
Allergan to Request Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading LawsAugust 27, 2014 8:27 am | News | Comments
Allergan has asked the United States District Court for the Central District of California to set an expedited schedule for discovery and a motion for a preliminary injunction against Valeant Pharmaceuticals, Pershing Square Capital Management, L.P., and its principal, William A. Ackman, for violations of the federal securities laws.
Allergan Inc. is reviewing shareholder requests for a special meeting to consider replacing most of its board, a change fellow drugmaker Valeant Pharmaceuticals International Inc. is seeking as part of the hostile takeover attempt it's been waging since April. Allergan has repeatedly...
Business isn't buying the Alabama Supreme Court's attempt to limit the fallout from its decision saying brand-name drugmakers can be held liable for warnings on generic medication produced by other companies. A majority of justices signed off on an opinion that went to lengths last week to say...
The prison agency in the nation's busiest death penalty state paid $13,500 for its most recent batch of pentobarbital at a cost of $1,500 per vial, compared to $350 per dose spent last year.
- Page 1